Clinical Trials Browser

Triple Negative Breast Neoplasms × Blood Specimen Collection × Clear all

NCT04331067 2026-05-06

Neoadjuvant Nivolumab and Chemotherapy in Patients With Localized Triple-negative Breast Cancer

Phase 1/2 Active not recruiting

15 enrolled 12 charts

Triple Negative Breast Neoplasms

NCT07570524 2026-05-06

PRIME-TNBC

Not yet recruiting

Triple Negative Breast Neoplasms

NCT04068623 2026-03-20

PERCEPTION

Active not recruiting

Triple Negative Breast Neoplasms

NCT07421479 2026-02-19

PDO-Mercurial

Active not recruiting

Triple Negative Breast Neoplasms

NCT07260188 2025-12-03

PDO-Neo01

Triple Negative Breast Neoplasms

NCT04291950 2022-12-20

Epigenetics of TNBC in Overweight and Obese Hispanic & Non-Hispanic White Women

Breast Neoplasms, Obesity, Overweight, Triple Negative Breast Neoplasms

NCT00930930 2015-05-07

Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer

Phase 2 Completed

145 enrolled 10 charts

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms